We examined the associations between chronic diseases requiring hospitalization and the risk of nonmelanoma skin cancers (NMSCs) in a population-based case-control study of 4,187 patients diagnosed with a first primary NMSC in 1995 in Denmark. From the National Patient Registry covering all Danish hospitals, we obtained data on hospitalizations with chronic diseases, recorded before the date of NMSC diagnosis. Using incidence density sampling, we selected 10 age-, gender-, and residence-matched controls from the Danish Civil Registration System. We used conditional logistic regression to compute incidence rate ratios (IRRs) and 95% confidence intervals (CIs). Although no overall association was found between basal cell carcinoma (BCC) and hospitalization for chronic diseases, an elevated IRR for BCC was found among patients with connective tissue disease (IRR 1.34 (95% CI: 0.99-1.82)), transplants (IRR 8.00 (95% CI: 2.15-30)), and lymphoma (IRR 2.50 (95% CI: 1.29-4.84)). An overall association between squamous cell carcinoma (SCC) and hospitalization for chronic diseases was found and specific among patients with leukemia (IRR 7.75 (95% CI: 2.35-26)), lymphoma (IRR 3.86 (95% CI: 0.99-15)), and skin diseases ). Our study supports the presence of an association between certain chronic diseases and NMSC, and further suggests that these results unlikely are due to bias.
INTRODUCTION
An increased risk of non-melanoma skin cancer (NMSC) has been observed for patients with several chronic diseases, including other solid cancers (Frisch and Melbye, 1995; Frisch et al., 1996; Karagas et al., 1998 Karagas et al., , 1999 Milan et al., 2000; Rosenberg et al., 2004) , psoriasis (Frentz and Olsen, 1999) , atopic dermatitis (Olesen et al., 2005) , rheumatologic diseases (Mellemkjaer et al., 1996) , and lymphoma (Hjalgrim et al., 2000) . Further, elevated NMSC risks have been reported following certain treatments like radiation therapy and phototherapy, psoralen and long-wave ultraviolet radiation (psoralen plus ultraviolet light A (PUVA)) (Saladi and Persaud, 2005) , and use of immunosuppressants (Karagas et al., 2001; Sorensen et al., 2004) including among transplant recipients (Hartevelt et al., 1990; Caforio et al., 2000; Wong et al., 2003) . These studies generally focused on single risk factors or single treatments, and still it is not clear if the increased risk of NMSC is due to the chronic diseases or the treatments required for these diseases.
In a previous nationwide cohort study of NMSC patients in Denmark, we found a lower mortality among basal cell carcinoma (BCC) patients compared with that of the general Danish population (Jensen et al., 2006) . This led us to speculate that the observed links between chronic disease and NMSC might be due to biases such as surveillance bias (Berkson, 1946; Sorensen et al., 1996) . Therefore, we evaluated any association between NMSC and chronic diseases overall, using the population-based Danish National Patient Registry. Further, we examined whether a previous history of hospitalization for selected chronic diseases was a risk factor for a subsequent diagnosis of NMSC. To examine potential bias, our study design included additional analyses to rule out the effect of surveillance and selection bias on our results.
RESULTS

Descriptive data
We restricted our analyses to first primary cases, including cases with BCC (N ¼ 3,801, 91%) and squamous cell carcinoma (SCC) (N ¼ 386, 9%). Patients with BCC were, on average, younger than patients with SCC, with men accounting for about a half of the BCC patients and for about two-thirds of SCC patients (data not shown).
Chronic diseases as risk factors for BCC
Previous hospitalization for a connective tissue disease occurred in 1.3% of BCC cases and 1% of the controls. Organ transplantation occurred in 0.1% of the BCC cases compared with 0.01% of controls. A total of 0.3% cases and 0.1% controls had a previous hospitalization for lymphoma. Cases with BCC and their controls did not differ with respect to prevalence of cardiovascular disease, chronic pulmonary disease, renal disease, solid cancer, leukemia, or any severe skin disease (Table 1) .
Chronic diseases as risk factors for SCC
Four percent of the SCC cases and 3% of their controls had a prior hospitalization for chronic pulmonary disease. Organ transplantation occurred in 0.3% of the SCC cases compared with 0.03% of the controls. Leukemia hospitalizations had occurred in 1% SCC cases and 0.2% controls. A total of 0.8% of the SCC cases and 0.2% controls were previously hospitalized for lymphoma. Hospitalization for a severe skin disease occurred in 2% of SCC cases and 0.3% of controls. The prevalence of the other chronic diseases, we examined, were similar among SCC cases and controls (Table 1) .
Chronic diseases and the overall risk of NMSC
Eighty-seven percent of all cases with BCC had no chronic diseases before the date of diagnosis in 1995; the remaining 13% had at least one chronic condition that required hospitalization. A similar proportion was observed among the controls, with an incidence rate ratio (IRR) for BCC of 1.03 (95% confidence interval (CI): 0.93-1.14) among patients with at least one chronic disease. The IRR was 1.01 (95% CI: 0.90-1.13) for the medium (Charlson Comorbidity Index (CCI) ¼ 1-2) compared with the low comorbidity level (CCI ¼ 0). The IRR was 1.14 (95% CI: 0.92-1.42) for high (CCI42) compared with the low comorbidity level (CCI ¼ 0) (data not shown). After excluding disease categories, which are known to increase the risk for NMSC, the IRR for BCC was 0.97 (95% CI: 0.90-1.05) (Table 1, bottom).
Among cases with SCC, 77% had no hospitalizations for chronic diseases before the date of diagnosis in 1995, and 23% had at least one chronic disease requiring hospitalization. Among the controls, the respective prevalence before the index date was 83% and 17%. The overall IRR for SCC was 1.47 (95% CI: 1.14-1.91) in those with at least one chronic disease. Compared with patients with low comorbidity level (CCI ¼ 0), the IRR was 1.27 (95% CI: 0.95-1.71) in SCC patients with medium comorbidity level (CCI ¼ 1-2) and 2.46 (95% CI: 1.55-3.90) with high comorbidity level (CCI42) (data not shown). After excluding disease categories, which are known to increase the risk for NMSC, the IRR for SCC was 1.11 (95% CI: 0.86-1.43) (Table 1, bottom).
High-risk versus low-risk BCC and SCC
We found a similar proportion of cases and controls having had a history of hospitalization for a chronic disease when defining risk profile for BCC according to tumor size (X20 mm vs o20 mm). The IRR (X20 mm) was 1.59 (95% CI: 1.10-2.29) 
DISCUSSION
Our study supports the presence of an association between certain chronic diseases and non-melanoma skin cancer.
However, a major limitation of our study is that despite our large study size, our risk estimates were imprecise when we examined specific chronic diseases, in particular because of a very small numbers of SCC cases. Nonetheless elevated risks of NMSC were seen among patients with connective tissue disease, organ transplants and lymphoma, and severe skin diseases. These results are consistent with recent findings (Hartevelt et al., 1990; Mellemkjaer et al., 1996; Frentz and Olsen, 1999; Caforio et al., 2000; Hjalgrim et al., 2000; Wong et al., 2003; Olesen et al., 2005) suggesting that general immunosuppression is a major reason for NMSC development. How a condition with a chronic disease in general affects the immune system, and thereby the risk of NMSC, is less well known. The fact that the association persisted for SCC even after excluding disease categories, affecting the immune system and which are known to increase the risk for NMSC, indicates a relation between a chronic disease condition, the immune system, and NMSC.
We additionally found that individuals with chronic pulmonary disease were at higher risk of SCC, which to our knowledge has not been reported previously. One explanation is that smoking is associated both with SCC (Karagas et al., 1992; De Hertog et al., 2001 ) and chronic pulmonary disease. Another explanation is that steroid treatment is associated both with SCC (Karagas et al., 2001; Sorensen et al., 2004) and chronic pulmonary disease.
A major strength of our study is that we evaluated if our results were subject to surveillance bias. Arguing against surveillance bias, is that we found no overall association between the level of comorbidity and BCC risk. Moreover, if surveillance bias were present, we would expect an increased detection of smaller BCCs, which was not evident. In fact, if anything, an inverse relation was found. We found a stronger impact of a higher level of comorbidity on SCC risk compared with a lower level, raising the possibility of surveillance bias. However, we did not find that associations differed according to tumor size and level of differentiation of the SCCs, which would have supported the possibility of surveillance bias. The validity of case-control studies depends partly on the comparability of cases and controls, dependent on the manner in which they are selected (Karagas, 1993) . A major strength of our study compared with others is the availability of inpatient and outpatient skin cancer cases, as well as cases from different specialists (dermatologists, oncologists, plastic surgeons, and general practitioners), resulting in representation of a wide spectrum of NMSC severity. Additionally, we were able to select controls from the general population, thereby obtaining an unbiased control group (Karagas, 1993) . We further considered the possibility of under-ascertainment of especially BCC in patients with severe diseases (due to the triviality of BCC compared with this other disease). This would introduce a bias due to systematic differences in characteristics between those who are selected for study and those who are not (Jepsen et al., 2004) , because the selection of BCC cases would relate to patients with less severe chronic diseases. Potentially, this would lead to underestimation of the overall effect of chronic diseases on the risk of BCC (Brenner and Hakulinen, 2005) . We would expect this phenomenon to preferentially affect older patients; however, in our age-stratified analyses we found a similar risk of BCC in both younger and older age groups, arguing against this type of bias.
Another advantage of our study is that we used the discharge diagnoses from the Danish National Patient Registry, which comprises data on 99.4% of all discharges from Danish non-psychiatric hospitals, thereby avoiding recall bias (Karagas, 1993) . However, this is also a limitation because we have only assessed severe cases of chronic diseases and not the more common conditions that may not require hospitalization (ie, hypertension and diabetes). Another major limitation is that we were unable to adjust for the medications taken for the chronic diseases associated with an increased risk of NMSC. Therefore, we cannot completely rule out whether the association observed represents a biological or treatment effect.
In conclusion, we found an association between chronic diseases and BCC and SCC. This association persisted for SCC even after excluding disease categories, which are known to increase the risk of NMSC. Our results are unlikely due to biases but we cannot completely rule out that the observed associations represent a treatment effect.
MATERIALS AND METHODS
Cases of NMSC
In 1995, Professor Gerda Frentz established a nationwide case series by prospectively documenting all patients with NMSC seen by Danish dermatologists in 1995. Two sources were used to establish the series. The first included patients seen at private or public outpatient dermatology clinics, where the following clinical data were available: tumor site, size, and clinical diagnosis, whether the biopsy was sent for histological review, treatment type, and history of NMSCs. The second source comprised all patients with a histology review of suspected NMSCs, sent from any other nondermatology practitioner to a pathologist. These data also included biopsies diagnosed as NMSC, irrespective of the clinical diagnosis. Histological data on these tumors included the final histological diagnosis, the type of referring clinic, and if appropriate, details on the tumor's growth pattern, differentiation, and excision borders.
We classified tumors into high-risk and low-risk groups (Miller, 2000) according to tumor size (low risk as below 20 mm and high risk as above 20 mm), histological features of BCC tumors (nodular, superficial, and ulcerative were considered low risk, whereas sclerosing tumors were considered high risk), and the level of differentiation for SCC tumors (well-differentiated tumors were considered low risk, and poor or moderately differentiated ones were considered high risk; data missing on 11%).
All cases of the case serie were ascertained with a histological diagnosis performed by a dermatopathologist. Data on a history of NMSC were unavailable on this second source of cases in the case serie, and therefore were obtained by linkage to the Danish Cancer Registry (the Danish Cancer Registry is a population-based registry containing nationwide data on cancer cases since 1943; Storm et al., 1997) . Overall, there were 10,749 skin cancer patients (6,529 from the first source and 4,220 from the second source). These excluded 1,040 patients with Bowens Disease, keratoacanthoma and actinic keratosis, and other clinically misclassified as NMSCs. The remaining (9,709 patients) comprised first primaries (N ¼ 4,187) and new subsequent cases, as well as cases with an unknown history of NMSC (N ¼ 5,522). We only included cases with first primaries in the analyses.
General population controls
A unique 10-digit civil registration number, assigned to all Danish residents by the Danish Civil Registration System (Frank, 2000) , allows unambiguous data linkage between national registries. The Civil Registration System, which is updated daily, contains information for all Danish residents on vital status, date of death, and the area of residence. Approximately, 10 controls for each case were individually matched on age, gender, and area of residence, based on incidence density sampling (Wacholder et al., 1992) ; that is the controls had to be alive and at risk for a first NMSC at the time the corresponding case was diagnosed in 1995 (the index date assigned to controls). Data on the 41,314 controls were extracted.
Hospitalization due to chronic diseases
From the Danish National Patient Registry, we retrieved all hospital discharge diagnoses recorded between 1 January 1977 (the date the registry was established) and the date of the NMSC diagnosis for cases or index date for controls. Diagnoses were coded in ICD-8 system through 1993 and in the ICD-10 system thereafter. The National Patient Registry records 99.4% of all discharge records from Danish hospitals (Andersen et al., 1999) .
We examined the association of chronic diseases on the overall risk of NMSC by classifying diagnoses of chronic diseases into the www.jidonline.org 929 following nine categories: cardiovascular disease, chronic pulmonary disease, connective tissue disease, moderate to severe renal disease, organ transplants, cancer, leukemia, lymphoma, and severe skin disease (Table 3) .
We further examined the association of the level of chronic morbidity on the risk of NMSC by using the original diagnostic categories from the CCI (a validated index, developed to predict 1-year patient mortality using comorbidity data obtained from hospital chart review). In addition to conditions included as part of the CCI, we examined discharge diagnoses of patients with an organ transplant and severe skin diseases. Three levels of the comorbidity score were defined as follows: 0 (''low'') for persons with no underlying diseases listed in the Charlson Index; 1-2 (''medium''); and 42 (''high'') according to the disease categories of the originally CCI (Charlson et al., 1987) .
To evaluate whether the relation between chronic diseases and NMSC is only due to immune-related chronic diseases, we examined the remaining association of chronic morbidity after excluding disease categories, which are known to increase the risk of NMSC in the analyses (the categories of connective tissue diseases, renal diseases, organ transplants, cancer, leukemia, lymphoma, and severe skin diseases).
Statistical analysis
We used conditional logistic regression to compute incidence rate ratios IRRs and 95% CIs for NMSC, according to the chronic diseases overall and for each category (when using incidence density sampling, the estimated exposure odds ratio in a case-control design is an unbiased estimate of the IRR; Szklo and Nieto, 2000) .
To evaluate the presence of surveillance bias, we compared risk of NMSC across comorbidity levels of the CCI. Further, we compared the risk of high-risk (aggressive tumor behavior) versus low-risk tumors (less aggressive tumor behavior) according to size, histological feature, and level of differentiation (Miller, 2000) .
To examine a potential selection bias among cases being ascertained and cases not being ascertained, we conducted the analyses stratified by age groups (o61, 61-80, and X81 years). This analysis allowed us to explore if this phenomenon was differentially present as an indication of selection bias.
We considered BCC and SCC separately, and assigned patients to the category of SCC if both types were present. We analyzed data using STATA s software (version 9.0, STATA, College Station, TX). The study was approved by the Danish Data Protection Agency. 
